← ANALYSTS · TIPRANKS

Ashwani Verma · UBS

#1305among 12,504 TipRanks analysts★★★★★★★★★★
Hits 60% 96 of 161 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating +13.4% Over a year after the rating, TipRanks’ measure
Our companies rated now 20 Buy / hold / sell: 14 / 6 / 0
Upside of the analyst’s targets +38.6% Average over 20 current targets, to the last price
The market’s answer to the ratings +1.6% Day-0 move against SPY in the rating’s direction, average over 18 upgrades, downgrades and target changes
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Oct 14on TipRanks 07:15 CYTKIWMCytokinetics · $8.9B Reiterated Buy $115 → $104−9.6% +67.9% +4.0%next day +0.5%
Oct 14on TipRanks 07:11 MDGLMadrigal Pharmaceuticals · $10.4B Reiterated Buy $669 → $735+9.9% +63.4% +2.8%next day −0.3%
Oct 13on TipRanks Oct 14 06:25 UTHRUnited Therapeutics · $23.3B Reiterated Buy $725 +36.0% −1.2%next day +0.5%
Oct 13on TipRanks 07:25 ACADIWMACADIA Pharmaceuticals · $3.4B Downgrade Hold $49.00 → $23.00−53.1% +20.3% −4.1%next day +4.5%
Oct 7on TipRanks Oct 8 06:15 INSMInsmed · $21.5B Reiterated Buy $172 +78.7% −3.1%next day −0.8% · 5 days −2.9%
Oct 5on TipRanks 06:05 VTRSSPYViatris · $20.9B Reiterated Buy $23.00 → $26.00+13.0% +39.4% −0.6%next day −1.0% · 5 days −0.9%
Oct 2on TipRanks 10:15 LEGNLegend Biotech · $3.5B Assigned Hold $28.00 → $24.00−14.3% +29.9% −4.6%next day +0.4% · 5 days −0.9%
Sep 28on TipRanks Sep 29 06:20 NBIXNeurocrine · $13.9B Reiterated Buy $231 → $214−7.4% +57.7% +2.2%next day −1.3% · 5 days +1.5%
Sep 14on TipRanks Sep 11 08:09 JAZZJazz Pharmaceuticals · $13.9B Assigned Buy $315 → $337+7.0% +60.3% +1.4%next day +0.5% · 5 days −2.0%
Sep 8on TipRanks 06:07 RPRXRoyalty Pharma · $32.7B Assigned Buy $66.00 +8.3% −4.7%next day +0.5% · 5 days −2.4%
Sep 1on TipRanks 05:15 ASMBIWMAssembly Biosciences · $419M Initiated Buy $52.00 +158.8% +5.3%next day +3.9% · 5 days −6.6%
Aug 24on TipRanks Aug 21 06:50 ALVOAlvotech · $2.3B Assigned Buy $6.00 +20.0% +3.3%next day +18.8% · 5 days +11.3%
Aug 11on TipRanks Aug 10 06:35 MPLTIWMMapLight Therapeutics, Inc. · $446M Downgrade Hold $52.00 → $13.00−75.0% +68.8% +0.1%next day −1.3% · 5 days −7.6%
Aug 3on TipRanks 07:35 AMRXIWMAmneal Pharmaceuticals · $6.1B Reiterated Buy $23.00 → $25.00+8.7% +30.3% +1.5%next day −3.8% · 5 days −7.2%
Jul 28on TipRanks Jul 29 07:27 INCYSPYIncyte · $23.0B Reiterated Hold $113 −0.1% +9.1%next day −0.6% · 5 days −11.3%
Jul 2on TipRanks 08:55 EXELExelixis · $14.8B Assigned Hold $43.00 → $52.00+20.9% −16.4% +3.6%next day −1.4% · 5 days −0.2%
May 28on TipRanks May 29 06:10 BHVNIWMBiohaven Ltd. · $1.7B Reiterated Hold $11.00 +2.0% −9.9%next day +7.3% · 5 days +11.0%
May 13on TipRanks 05:40 CORTCorcept Therapeutics · $12.9B Upgrade Buy $72.00 −34.6% +11.0%next day +1.3% · 5 days +3.6%
May 6on TipRanks 06:40 ALKSIWMAlkermes · $6.7B Reiterated Buy $42.00 → $48.00+14.3% +16.4% −4.0%next day +0.5% · 5 days +9.0%
Apr 10on TipRanks 06:25 AXSMAxsome Therapeutics · $8.2B Assigned Buy $251 → $259+3.2% +64.8% −0.4%next day −0.9% · 5 days +1.6%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗